Nutrition and Obesity

Over the last few decades, obesity has become the most prevalent metabolic disorder worldwide. Excess adiposity increases the risk for the development of cardiometabolic alterations such as type 2 diabetes, cardiovascular disease, dyslipidemia, non-alcoholic fatty liver disease and cancer, among others. In the last few years, our knowledge of obesity has greatly improved, but more research is needed to better understand the mechanisms underlying the development of this metabolic condition and its pathophysiology, and to optimize its management.

We welcome original research articles describing basic, clinical and applied studies representing novel and significant advances in all areas relevant to obesity and related disorders, as well as reviews. The areas of research covered by this section relate to all aspects of obesity diagnosis, pathophysiology and treatment.

Topics include, but are not limited to:

• Obesity;
• Adipose tissue pathophysiology;
• Biomarkers;
• Physical activity;
• Adipokines;
• Pediatric obesity;
• Obesity phenotyping;
• Omic studies;
• Regulation of appetite;
• Body composition;
• Energy expenditure;
• Genetics;
• Cardiometabolic risk factors;
• Nutritional epidemiology;
• Animal models;
• Aging;
• New technologies (for phenotyping or treatment);
• In vitro models, including organoids;
• Psychological aspects;
• Metabolic syndrome;
• Type 2 diabetes;
• Non-alcoholic fatty liver disease;
• Other obesity-related metabolic disturbances;
• Dietary treatment;
• Lifestyle intervention;
• Pharmacological treatment;
• Metabolic surgery;
• Intermittent fasting;
• Cardiometabolic risk improvement after weight loss;
• Body composition changes;
• Weight regain;
• Predictors of treatment success;
• Use of apps for weight loss;
• Novel targets;
• Transgenerational effects;
• Treatment of children and adolescents.